Annaly Capital (NLY) Announces Chairman/CEO's Treatment Completed, Cancer in Remission
Tweet
Share
E-mailGet Alerts NLY Hot Sheet
Join SI Premium – FREE
Annaly Capital Management, Inc. (NYSE: NLY) today announced that its Chairman, President and Chief Executive Officer, Michael A.J. Farrell, has completed his treatment program and that his cancer is in remission.
“There are no certainties in life, but I feel good and have been given an encouraging prognosis,” said Mr. Farrell. “This good news was made possible because of my terrific medical team and the support of my family, friends and colleagues, and I want to thank them for that. I look forward to continuing my work and, along with my very capable management team, remain committed to our mission of delivering strong, income-based returns to Annaly shareholders.”
Mr. Farrell continued: “Looking ahead, I believe there are many risks in the marketplace, including slow economic growth, uncertainty in Europe and the future of monetary policy. Our management team has maintained a relatively conservative operating profile that is designed to prepare us for this environment and position us for a wide range of outcomes. I believe it has set us on a path to continue to generate attractive risk-adjusted returns over the long-term.”
“There are no certainties in life, but I feel good and have been given an encouraging prognosis,” said Mr. Farrell. “This good news was made possible because of my terrific medical team and the support of my family, friends and colleagues, and I want to thank them for that. I look forward to continuing my work and, along with my very capable management team, remain committed to our mission of delivering strong, income-based returns to Annaly shareholders.”
Mr. Farrell continued: “Looking ahead, I believe there are many risks in the marketplace, including slow economic growth, uncertainty in Europe and the future of monetary policy. Our management team has maintained a relatively conservative operating profile that is designed to prepare us for this environment and position us for a wide range of outcomes. I believe it has set us on a path to continue to generate attractive risk-adjusted returns over the long-term.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Annaly Capital to redeem 17.7M Series I preferred shares at $25
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
